FLUID PHYSICS BIOTECHNOLOGY PLATFORM

Physical Targeted Delivery System for Human Health Enhancement

Physical Targeted Delivery System for Human Health Enhancement

Physical Targeted Delivery System for Human Health Enhancement

A non-chemical, solid-state architecture engineered for precision interaction across dermal, cranial, and gastric enhancement pathways.

A non-chemical, solid-state architecture engineered for precision interaction across dermal, cranial, and gastric enhancement pathways.

A non-chemical, solid-state architecture engineered for precision interaction across dermal, cranial, and gastric enhancement pathways.

IMMERSIVE FLUID SIMULATION

LIVE MODEL 04

Placeholder for macro-fluid particle field video — laminar targeting model, non-reactive carrier dynamics, and solid-state interface behavior.

CORE TECH MATRIX

CORE TECH MATRIX

Engineered as a physical platform, not a chemical formulation.

Engineered as a physical platform, not a chemical formulation.

Engineered as a physical platform, not a chemical formulation.

100% Pure Physical Solid-State Architecture

A precision material interface designed to modulate targeted delivery behavior through structure, surface energy, and physical activation.

Zero Chemical Additives. Live-Fish Eco-Safety Verification.

Validated through ecological observation workflows where organism viability is used as a clear, high-sensitivity safety signal.

Germany Dermatest “Excellent” Seal

Germany Dermatest “Excellent” Seal

External dermatological screening supports the platform’s clinical-grade positioning for premium human health enhancement programs.

PRODUCTIZED PATHWAYS

3-Tier Human Enhancement Solutions

3-Tier Human Enhancement Solutions

3-Tier Human Enhancement Solutions

TIER 01 · DERMAL

Facial Detox

Nanogel interface for premium skin detox positioning and high-compliance wellness programs.

Cranial Neuro

Scalp treatment pathway for neuro-care, circulation ritual, and high-touch clinical spa deployment.

Gastric Block

Cryo-shot format for metabolic wellness partners and structured intake protocols.

Designed for licensing, clinical distribution, and cross-border B2B commercialization.

JP · EU · USA

EMPIRICAL VALIDATION LAB

EMPIRICAL VALIDATION LAB

168-hour aggregation proof gallery

168-hour aggregation proof gallery

168-hour aggregation proof gallery

T+168H / MACRO CLUSTER FIELD

Lab aggregation photo placeholder

Microparticle convergence

Surface-energy behavior

Fluid suspension clarity

168-hour stability window

CORPORATE SCREENING INQUIRY

For pharma conglomerates, clinical distributors, and strategic commercialization partners.

For pharma conglomerates, clinical distributors, and strategic commercialization partners.

For pharma conglomerates, clinical distributors, and strategic commercialization partners.

Submit a confidential inquiry for Japan, EU, or USA screening. Pura Akvo evaluates strategic fit, territory logic, and validation pathway readiness before releasing technical documentation.

JAPAN

EU

USA